Table 4 Distribution of PPIs dispensations between 2017 and 2020 in chronic consumer patients
PPI | Dosage | 2017 (%) | 2018 (%) | 2019 (%) | 2020 (%) |
|---|---|---|---|---|---|
ESOMEPRAZOLE | 10 mg | 0.12 | 0.14 | 0.14 | 0.13 |
20 mg | 22.31 | 22.03 | 21.87 | 21.67 | |
40 mg | 17.88 | 17.97 | 17.78 | 17.70 | |
LANSOPRAZOLE | 15 mg | 6.75 | 7.11 | 7.70 | 8.18 |
30 mg | 5.84 | 6 | 6.21 | 6.44 | |
OMEPRAZOLE | 10 mg | 3.66 | 3.69 | 3.54 | 3.49 |
20 mg | 14.73 | 14.66 | 14.14 | 13.78 | |
PANTOPRAZOLE | 20 mg | 12.02 | 12.17 | 12.65 | 12.79 |
40 mg | 7.57 | 7.85 | 7.87 | 8.08 | |
RABEPRAZOLE | 10 mg | 3.74 | 3.38 | 3.20 | 2.96 |
20 mg | 5.39 | 4.99 | 4.89 | 4.78 |